All the events here are relevant to people working in dementia research. If you would like to add your own you can submit an event
Salon – Population-level Dementia Risk Reduction
July 23 @ 8:00 pm - 9:00 pm
A weekly webinar to discuss careers and research topics. These sessions combine livestreams, guest speakers, and group online chat to exchange ideas, challenge, influence, inspire, and educate. In this session we hear from Dr Sebastian Walsh fom University of Cambridge and Dr Adrián Noriega de la Colina from Perceiv AI discussing Population-level Dementia Risk Reduction.
When it comes to tackling dementia, treatment is only part of the story—what if we could reduce risk before symptoms even begin? Population-level dementia risk reduction shifts the focus from cure to prevention, asking bold questions about how lifestyle, environment, and public health policies can shape brain health across society. But how do we turn individual findings into scalable strategies? What works, for whom, and how can we measure real-world impact? Today, we’ll explore how dementia researchers can help move the needle—shaping interventions that not only inform but transform lives on a global scale.
Speakers
Dr Seb Walsh is an NIHR Doctoral Fellow (2022–25), researching population-level approaches to dementia risk reduction. Their PhD work involves mixed methods, including quantitative analysis, qualitative interviewing, policy analysis, and systematic reviewing. With a background as an applied public health academic, they have been training as a public health specialty registrar in the East of England region since 2018.
Dr Noriega de la Colina is the CIHR–Institute of Aging Fellow at the Montreal Neurological Institute-Hospital and Clinical Lead at Perceiv AI. A physician and research scientist at McGill University and affiliated with the Douglas Research Centre, he focuses on neurodegenerative diseases, particularly Alzheimer’s. He has led digital biomarker development and clinical trial strategies in phase II and III studies, using diverse datasets to support disease forecasting and patient-centred, value-based care. He is also a World Heart Federation Emerging Leader and MIT Catalyst Fellow.
